KALA - kalarx.com Debt to Book Capitalization Ratio

The daily price chart for KALA BIO, Inc. (KALA) reflects the asset's dynamics, with a value of 0.00. KALA BIO, Inc. (KALA) is scaling its developments in stem cell secretomes to combat corneal inflammation and damage. The brand's high authority among surgeons is driven by the application of unique cellular technologies. The industry's specifics guarantee resilient demand even during a recession, as ophthalmological care remains critically important.

This ratio determines the proportion of borrowed funds relative to equity, measuring the extent to which financial stability depends on external obligations. By analyzing debt obligations against the balance sheet capital structure, an investor assesses the ability of KALA BIO, Inc. (KALA) to finance the expansion of its stem cell secretome platform and the development of ophthalmology drugs without a critical risk of insolvency.